Captor Therapeutics ® Investor Relations

      Investor Relations

      Appointment of an audit firm (extension of an audit agreement)

      Publication date: 2021-07-22
      Number: RB ESPI 24/2021

      Current report no. 24/2021

      Date of preparation: 22 July 2021

      Subject: Appointment of an audit firm (extension of an audit agreement)

      Legal basis: Article 17 sec. 1 of MAR – inside information.

      The Management Board of Captor Therapeutics S.A. with its registered office in Wrocław (the “Company”), informs that on 22 July 2021 it became aware that on the same day the Supervisory Board of the Company passed a resolution on the extension of an agreement for the audit of financial statements and appointment of Mazars Audyt sp. z o.o. with its registered office in Warsaw, KRS 0000086577, as the audit firm to carry out:

      1. an audit of separate and consolidated financial statements of the Company for fiscal years 2021 and 2022; and
      2. review of separate and consolidated semi-annual financial statements of the Company for the first half of 2021 and 2022.

      The audit firm was appointed after the review by the Supervisory Board of the Company with the recommendation of the Audit Committee of the Supervisory Board of the Company, prepared in accordance with the provisions of law and internal regulations of the Company, expressed in the form of a resolution of the Committee of 20 July 2021.

      The Company used the services of Mazars among others with respect to the audit and review of financial statements for 2020 and historical financial information of the Company included in the Company’s prospectus approved on 22 March 2021 by the Financial Supervision Authority.